Significant fibrosis (METAVIR F ≥ 2) | |||||
---|---|---|---|---|---|
Test | APRI | M-APRI | FIB-4 | M-FIB-4 | B-AST |
AUROC (95% CI) | 0.752 (0.561–0.890) | 0.842 (0.663–0.948) | 0.708 (0.514–0.859) | 0.823 (0.641–0.937) | 0.848 (0.670–0.952) |
Cut-off | 0.656 | 0.577 | 0.180 | 0.179 | 92.82 |
Sensitivity (95% CI) | 57.1 (18.4–90.1) | 71.4 (29.0–96.3) | 85.7 (42.1–99.6) | 71.4 (0.29–96.3) | 71.4 (0.29–96.3) |
Specificity (95% CI) | 91.3 (72.0–98.9) | 95.6 (78.1–99.9) | 65.2 (42.7–83.6) | 91.30 (72.0–98.9) | 95.7 (78.1–99.0) |
+ PV | 66.7 (31.5–89.7) | 83.3 (41.0–97.3) | 42.9 (28.4–58.6) | 71.4 (38.0–91.1) | 83.3 (41.0–97.3) |
- PV | 87.5 (74.7–94.3) | 91.7 (77.3–97.3) | 93.7 (70.5–99.0) | 91.3 (76.4–97.2) | 91.7 (77.3–97.3) |